Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray (TSX:TLRY) launches new products and 'CannaPoints' program to support patients across Canada

Azuka Onwuka, The Market Herald
0 Comments| August 25, 2022

{{labelSign}}  Favorites
{{errorMessage}}

  • Tilray Brands (TLRY) has announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products under Tilray and Aphria brands
  • Tilray Medical also launched CannaPoints, a new program to support patients through their medical cannabis journey
  • Tilray Medical’s latest release of medical cannabis products from differentiated brands includes a comprehensive range of THC and CBD products
  • Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis
  • Tilray Stock (TSX:TLRY) opened the day’s trading at $4.88 per share

Tilray Brands (TLRY) has announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands.

Tilray Medical also launched CannaPoints, a new program to support patients through their medical cannabis journey.

“We’re proud to expand our medical cannabis portfolio in Canada and broaden our offerings for our growing patient community,” said Blair MacNeil, President, Tilray Canada.

“Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed,” he added.

In Canada, Tilray Medical offers a broad portfolio of medical cannabis brands including Tilray, Aphria, Broken Coast, and Symbios.

Tilray Medical’s latest release of medical cannabis products from differentiated brands includes a comprehensive range of THC and CBD products.

Under the Tilray and Aphria brands, the company released Tilray Sinaloa Gold, Tilray Sapphire Scout, Tilray Chem Cookies, and Tilray Powdered Donuts #8. And under the Aphria brands, it released Aphria Sherbet Cookies, Aphria Banana Punch, and Aphria Monkey Butter.

To further support the medical cannabis journey for patients, Tilray Medical partnered with Strainprint, a mobile app focused on medical cannabis tracking, to develop the CannaPoints
program.

Alongside advice from a physician, Tilray Medical patients can use the CannaPoints program to explore new offerings, learn more about strain details, and record the effects, making it easier for them to curate optimal personal consumption schedules, empowering them to tailor their own experiences and earn rewards through the app in the process.

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis.




{{labelSign}}  Favorites
{{errorMessage}}


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company